The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells - 10/09/11
Abstract |
The relative contribution of IL-4 and IL-13 to the regulation of IgE synthesis has remained relatively poorly characterized, partially because of lack of suitable animal models. We have studied the roles of IL-4 and IL-13 in human IgE synthesis induced by supernatants derived from activated CD4++ or CD8+ T cell clones. Neutralizing anti–IL-4 and anti–IL-13 monoclonal antibodies (mAbs) inhibited IgE synthesis induced by anti-CD40 mAbs and supernatants from CD4+ T cells by an average 61% and 42%, respectively (n = 25). Recombinant IL-13 had additive effects on IL-4-induced IgE synthesis, but only when IL-4 was present at low concentrations. Accordingly, IL-4 was the dominant IgE synthesis–inducing cytokine derived from highly polarized T helper (TH)2 cells. However, anti–IL-13 mAbs also significantly inhibited IgE synthesis induced by two of three supernatants derived from allergen-specific TH2-like cell lines generated from the skin of patients with atopic dermatitis. Furthermore, anti–IL-13 mAbs almost completely inhibited IgE synthesis induced by supernatants from TH1 cells or CD8+ T cell clones. Taken together, these data indicate that IL-13, in addition to IL-4, contributes to IgE synthesis induced by all T helper cell subsets, including allergen-specific TH2 cells. Moreover, IL-13 appears to be the major IgE synthesis–inducing cytokine derived from TH1 cells or CD8+ T cells. (J Allergy Clin Immunol 1997;100:792-801.)
Le texte complet de cet article est disponible en PDF.Keywords : B lymphocytes, allergy, cytokines, isotype switching, T helper cells
Abbreviations : CD40L:, FCS:, IFN-γ:, IGF-1:, mAbs:, MNC:, PBMC:, TH0, TH1, TH2:
Plan
| From the Human Immunology Department, DNAX Research Institute of Molecular and Cellular Biology, Inc., Palo Alto. |
|
| Supported by Schering-Plough Corporation and by the Academy of Finland (J.P.). |
|
| Reprint requests: Jan E. de Vries, PhD, Human Immunology Department, DNAX Research Institute of Molecular and Cellular Biology, Inc., 901 California Ave., Palo Alto, CA 94304-1104. |
|
| 1/1/84508 |
Vol 100 - N° 6
P. 792-801 - décembre 1997 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
